Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-18

Clinical Trial Update: Eltrombopag for Peripheral Blood Stem Cell Harvest [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Taiwan is evaluating eltrombopag to improve peripheral blood stem cell harvest in patients with lymphoma undergoing transplantation.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eltrombopag (eltrombopag)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Lymphoma, Peripheral Blood Stem Cell Transplantation | Phase 2 | Status: RECRUITING